Reponex Pharmaceuticals A/S
🇩🇰Denmark
Effect of rhGM-CSF on the Healing of Venous Leg Ulcers
Phase 2
Active, not recruiting
- Conditions
- Venous Leg Ulcer
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Reponex Pharmaceuticals A/S
- Target Recruit Count
- 6
- Registration Number
- NCT04823962
- Locations
- 🇩🇰
Department of Dermatology and Copenhagen Wound Healing Center, Bispebjerg Hospital, Copenhagen, Denmark
© Copyright 2025. All Rights Reserved by MedPath